Per citar aquest document: http://ddd.uab.cat/record/28205
The origin of the production of diphtheria antitoxin in France, between philanthropy and commerce
Simon, Jonathan

Data: 2007
Resum: Serotherapy for the treatment of diphtheria represented a major therapeutic innovation at the end of the nineteenth century. The manner in which large-scale production of this medicament was undertaken and the regulations that governed its production and distribution were important elements of public health policy in France as in other European countries. This paper describes the dominance of the Pasteur Institute in this field and, starting from this observation, explores what this event in the history of medicine can tell us about the governance of public health in fin-de-siècle France. The particular organization of this institute and its monopoly of specialist microbiological knowledge allowed it to raise money for serum production from both private and public sources, walking the line between a commercial pharmaceutical venture and a philanthropic enterprise.
Drets: Article de fons Creative Commons
Llengua: Anglès.
Document: article ; recerca ; publishedVersion
Matèria: Seroterapia ; Institut Pasteur ; Tercera República ; Creu ; Salut Pública ; Instituto Pasteur ; Cruz ; Salud Pública ; Serotherapy ; Pasteur Institute ; Third Republic ; Croup ; Public Health
Publicat a: Dynamis : Acta Hispanica ad Medicinae Scientiarumque. Historiam Illustrandam, V. 27 (2007) p. 63-82, ISSN 0211-9536

Adreça alternativa: http://www.raco.cat/index.php/Dynamis/article/view/114298


20 p, 270.3 KB

El registre apareix a les col·leccions:
Articles > Articles publicats > Dynamis : Acta Hispanica ad Medicinae Scientiarumque
Articles > Articles de recerca

 Registre creat el 2008-08-14, darrera modificació el 2016-06-12



   Favorit i Compartir